首页> 外文OA文献 >Autoimmune-Like Antibodies to the Ligand-Binding Sites of Myeloma Proteins
【2h】

Autoimmune-Like Antibodies to the Ligand-Binding Sites of Myeloma Proteins

机译:骨髓瘤蛋白配体结合位点的自身免疫样抗体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BALB/c mice were immunized with three A-myeloma proteins of BALB/c-2 or BALB/c origin (produced by plasmacytomas MOPC-315, MOPC-460, Adj. PC-22A). Noncross reacting antibodies were formed against Proteins-315 and 460, but the response to Protein-22A was marginal. Proteins-315 and 460 have anti-dinitrophenyl activity, and their reactions with the corresponding BALB/c antibodies were inhibited by dinitrophenyl ligands. It appears that antibodies can be formed in BALB/c mice against unique “idiotypic” determinants in the ligand-binding sites of some BALB/c mycloma proteins.
机译:用三种BALB / c-2或BALB / c来源的A-骨髓瘤蛋白(由浆细胞瘤MOPC-315,MOPC-460,Adj.PC-22A产生)免疫BALB / c小鼠。形成了针对Proteins-315和460的非交叉反应抗体,但对Protein-22A的反应很小。蛋白质315和460具有抗二硝基苯基活性,并且它们与相应的BALB / c抗体的反应受到二硝基苯基配体的抑制。似乎可以在BALB / c小鼠中形成针对某些BALB / c支原体蛋白质配体结合位点中独特的“独特型”决定簇的抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号